Gene Query: SEC22B

Dataset Description Geneva Score
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 34.98
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 26.69
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 25.01
Sensing self and nonself circular RNAs 24.7
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 22.37
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 22.11
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 22.11
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 20.63
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 20.37
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 20.3
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 19.85
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 19.76
hnRNP C is a key regulator of protein synthesis in mitosis 19.23
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 19.13
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 18.96
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 18.68
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 18.45
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 18.45
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 18.2
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 18.06
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 18.06
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 18.03
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 17.57
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 17.57
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 17.49
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 17.19
ETV7 and interferon response 17.19
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 17.05
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 16.64
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 16.41
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 16.41
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 16.36
Role of microRNAs in the interaction between Salmonella and the host cell 16.22
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 16.12
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 15.85
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 15.34
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 15.31
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 15.21
Human cell line and subcutaneous tumor 15.06
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 14.96
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 14.92
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 14.79
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 14.79
Zika infected neural stem cells 14.67
Transcriptome analysis of Zika infected neural stem cells 14.67
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 14.65
Cerebellar differentiation in Ataxia-Telangiectasia 14.55
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 14.45
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 14.32
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 14.17
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 14.12
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 14.12
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 14.03
Argonaute proteins couple chromatin silencing to alternative splicing 14.0
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 14.0
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 13.97
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 13.96
Genome wide expression change in LCC2 and MCF-7 cells 13.81
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 13.67
Conservative alteration of chromosomal expression pattern across human solid tumor types 13.33
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 13.22
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 13.13
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 13.09
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 12.88
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 12.87
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 12.82
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.8
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 12.72
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 12.61
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 12.6
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 12.59
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 12.56
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 12.5
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 12.45
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 12.34
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 12.23
Transcriptome analysis of kidney organoids 12.13
RNA-Seq analysis of breast cancer cells after shikonin treatment 12.08
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 12.06
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 12.06
A549 cells and MSR-A549 cells 12.06
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 12.05
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 12.01
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 11.99
MYCi361 regulates MYC target genes 11.94
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 11.76
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 11.76
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 11.75
Gene expression analysis of dengue-infected cells 11.61
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 11.59
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 11.53
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 11.53
Modeling Familial Cancer with iPSC Approaches 11.51
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 11.46
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 11.34
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 11.25
Global expression profiles in cardiac progenitor cells generated by ISX-9 11.14
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 11.14
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 11.07
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 11.04
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 10.99
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 10.96
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 10.94
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 10.93
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 10.85
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 10.83
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 10.71
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 10.61
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 10.61
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 10.6
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 10.49
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 10.45
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 10.37
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 10.37
Mitochondrial dsRNA triggers antiviral signalling in humans 10.35
Triple vectors expand AAV transfer capacity in the retina 10.3
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 10.23
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 10.2
RNA sequencing of primary human platelets and in vitro cell lines 10.19
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 10.15
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 10.12
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 10.05
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 10.0
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 9.95
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 9.95
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 9.9
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 9.89
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 9.88
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 9.7
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 9.7
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 9.59
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 9.55
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 9.52
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 9.52
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 9.51
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 9.5
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 9.5
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 9.44
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 9.43
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 9.41
Unique features and clinical importance of acute alloreactive immune responses 9.41
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 9.41
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 9.38
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 9.34
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 9.31
Genome-wide discovery of human splicing branchpoints [RNAse] 9.28
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 9.27
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 9.27
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 9.26
MCF10A H-Ras RNA-Seq 9.24
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 9.22
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 9.22
CROP-Seq in Primary Human T Cells 9.21
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 9.19
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 9.18
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 9.17
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 9.14
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 9.1
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 9.07
RNA-seq analysis of BAP1-depleted uveal melanoma cells 9.03
RNA sequencing of GlyH-101-treated MCF-7 cell line 9.03
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 8.93
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 8.92
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 8.91
SLIGRL-induced gene expression changes in NHEK cells 8.89
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.89
RNA-seq of human aneuploid cell lines with Trisomy 21 8.86
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 8.83
Transcriptomic analysis of LSD1 8.69
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 8.67
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 8.67
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 8.65
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 8.64
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 8.64
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 8.62
Postnatal lipids drive hepatocyte maturation 8.59
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 8.57
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 8.56
PNET animal model: new insights (II) 8.54
DJ-1 is dispensable for human stem cell homeostasis 8.54
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 8.53
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 8.5
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 8.48
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 8.46
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 8.38
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 8.37
Dtx3L and Androgen Signaling in Prostate Cancer 8.35
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 8.34
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 8.33
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 8.31
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 8.29
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 8.29
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 8.24
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 8.24
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 8.15
Differential gene expression of human melanoma cells [RNA-seq] 8.15
Next generation sequencing of small RNAs isolated from exosomes in human semen 8.12
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.12
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.11
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.08
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 8.06
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 8.03
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 8.03
High-efficiency RNA-based reprogramming of human primary fibroblasts 8.0
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 8.0
Genome-wide functional assessment of enhancer activities in the human genome 7.97
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 7.96
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 7.95
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 7.93
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 7.88
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 7.87
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 7.85
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 7.82
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 7.8
Genome wide expression change by RNF168 knocking down in MCF-7 cells 7.76
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 7.75
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 7.73
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.73
Transcriptome-wide modulation of splicing by the exon junction complex 7.73
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.71
Short and Long RNA sequencing of human mature erythrocytes 7.68
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 7.61
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.61
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 7.6
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 7.6
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 7.6
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 7.59
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 7.56
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 7.56
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 7.56
A role for ZNF598 in post-transcriptional gene regulation 7.54
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 7.51
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 7.5
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 7.47
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 7.46
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.43
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.41
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 7.38
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 7.34
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 7.34
The human blood-nerve barrier transcriptome 7.33
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 7.31
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 7.28
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 7.28
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 7.28
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 7.22
RNA Seq of HMVEC under hypoxia 7.22
The conserved transcriptional landscapes in human spermatogenesis 7.2
MYC dependent mRNA translation shapes gene expression and cell biology 7.2
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 7.17
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 7.12
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 7.12
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 7.1
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 7.02
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 6.98
CDK12 mediated transcriptional regulation in U2OS cells 6.96
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 6.96
Human HAP1 cells before and after nutrient deprivation 6.87
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.87
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 6.86
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 6.82
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 6.82
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 6.72
Hepatitis C virus functionally sequesters miR-122 6.67
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 6.67
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.59
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 6.57
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 6.5
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 6.48
Differetially expressed genes after hTR overexpression in U2OS cells 6.44
Electronic cigarettes 6.43
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.38
Novel Targeting of Transcription and Metabolism in Glioblastoma 6.26
nELAVL HITS-CLIP in Alzheimer's Disease patients 6.25
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 6.23
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.2
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 6.19
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.1
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 6.06
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 5.92
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 5.87
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 5.87
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 5.84
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.77
The Genomic Landscape of Atypical Fibroxanthoma 5.73
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.7
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 5.65
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 5.61
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 5.6
Lipid degradation promotes prostate cancer cell survival 5.59
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 5.59
X-Ray induced DNA-Hydroxymethylation changes 5.49
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 5.49
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.49
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 5.42
Effect of PBK knockdown on C4-2 cell transcriptome 5.36
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 5.35
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.29
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.1
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 5.08
Hepatocyte maturation 5.03
Transcriptomic analysis of the HOTAIR-regulated genes 5.0
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 4.99
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 4.98
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 4.96
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 4.93
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 4.92
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 4.92
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 4.91
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 4.89
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 4.87
Illumina Total RNA-seq in HeLa 4.69
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 4.63
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.6
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 4.59
K562 polyA RNA-Seq 4.59
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.54
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 4.47
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 4.43
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 4.41
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 4.4
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 4.39
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 4.39
In situ CAPTURE of chromatin interactions by biotinylated dCas9 4.34
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 4.34
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 4.29
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.29
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 4.28
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 4.28
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 4.25
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.23
Biological effect of chronic mistranslation in mammalian cells 4.18
Systematic discovery of endogenous human ribonucleoprotein complexes 4.14
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.12
An optimization system for isolating and sequencing of single human colon cancer cells 4.06
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 4.0
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 3.94
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.93
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 3.89
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 3.87
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.85
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.85
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 3.77
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 3.77
The transcriptome effect of overexpressing EZH2 in MCF7 3.74
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.73
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.7
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 3.65
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 3.52
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.51
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 3.46
mRNA expression in human DAOY cells 3.45
Tpl-2 small molecule project 3.44
Tpl-2 and MEK small molecule inhibitors 3.44
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.44
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.44
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.42
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.42
RNA-Seq of PRMT1 overexpression ECA109 cells 3.4
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 3.37
6mer seed toxicity in viral microRNAs 3.36
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 3.34
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.3
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.29
Transcriptome analysis of peripheral blood monocytes 3.27
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 3.25
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.24
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.22
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 3.18
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 3.18
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 3.18
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 3.17
Measure transcript integrity using RNA-seq data 3.16
mRNA sequencing of oropharyngeal cancer cell lines 3.15
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.13
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 3.13
The role of CFTR in islet function 3.1
naive T cell heterogeneity after neonatal thymectomy 3.05
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 3.05
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.93
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 2.93
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.8
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.8
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 2.71
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.7
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.68
Copper Regulation of HIF-1 Transcription Activity 2.6
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.6
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.44
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.41
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.41
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.41
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.37
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.37
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.31
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.29
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.26
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.23
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.23
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.22
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.21
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.21
A single-cell transcriptome atlas of the human pancreas 2.21
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.2
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.2
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.16
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.11
RNA-seq of IL-4 stimulated human keratinocytes 2.09
Role of cervicovaginal microbiota in genital inflammation 2.07
Transcriptome profiling of 5 human adenocarcinoma cell lines 2.03
Identification of global XBP1s target gene expression in human prostate cancer cells 2.02
Determination of tRNA aminoacylation levels by high throughput sequencing 2.02
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.97
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.94
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.94
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.94
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.89
MAIT cell RNA sequencing 1.88
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.76
Human Tfh cell RNA bulk sequencing 1.66
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 1.62
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.61
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.61
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.6
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.57
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.56
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.56
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.51
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.51
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.45
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.38
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.37
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.34
Evaluating pre-clinical models for studying NASH driven HCC. 1.31
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.31
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.31
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.31
Gene expression profile of human placenta from T. Cruzi infected mothers 1.25
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.24
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.23
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.17
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 1.11
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 1.11
mRNA recovered upon RNF219 IP. [RNA-IP] 1.08
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 1.07
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.06
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.06
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.04
Myc activation coordinates gene transcription and protein translation responses 1.03
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.98
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.95
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.95
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.86
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.82
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.81
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.81
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 0.8
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.77
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.76
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.71
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.71
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.7
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.7
Metabolism as an early predictor of DPSCs aging 0.68
Interphase condensins regulate ligand-depedent enhancer activation 0.66
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.66
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.65
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.64
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.63
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.63
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.59
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.59
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.53
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.46
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.46
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.46
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.43
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.42
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 0.41
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.39
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.38
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.34
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.34
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.29
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.27
High-resolution comparative analysis of great ape genomes 0.27
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 0.26
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.19
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.19
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.16
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.14
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.13
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.13
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 0.11
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 0.11
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.1
Aging-associated patterns in the expression of human endogenous retroviruses 0.09
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.02
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation